WASHINGTON--(BUSINESS WIRE)--After conducting a thorough and rigorous regulatory review, the U.S. Food and Drug Administration (FDA) has approved the genetically engineered (GE) AquAdvantage® Salmon for commercial marketing.
In response to FDA’s approval of AquAdvantage® Salmon, Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood issued the following statement:
“BIO commends the FDA for taking this very important step in the right direction for the advancement of animal biotechnology innovation.
